FI20116008A0 - Viskeraalisen rasvan estäminen ja diagnostisointi - Google Patents

Viskeraalisen rasvan estäminen ja diagnostisointi

Info

Publication number
FI20116008A0
FI20116008A0 FI20116008A FI20116008A FI20116008A0 FI 20116008 A0 FI20116008 A0 FI 20116008A0 FI 20116008 A FI20116008 A FI 20116008A FI 20116008 A FI20116008 A FI 20116008A FI 20116008 A0 FI20116008 A0 FI 20116008A0
Authority
FI
Finland
Prior art keywords
visceral fat
bifidobacteria
diagnosis
prevention
relates
Prior art date
Application number
FI20116008A
Other languages
English (en)
Swedish (sv)
Original Assignee
Maeyrae Maekinen Annika
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maeyrae Maekinen Annika filed Critical Maeyrae Maekinen Annika
Priority to FI20116008A priority Critical patent/FI20116008A0/fi
Publication of FI20116008A0 publication Critical patent/FI20116008A0/fi
Priority to PCT/FI2012/050979 priority patent/WO2013054002A1/en
Priority to EP12839611.6A priority patent/EP2766026B1/en
Priority to DK12839611.6T priority patent/DK2766026T3/en
Priority to ES12839611.6T priority patent/ES2660396T3/es
Priority to US14/350,957 priority patent/US10000818B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4869—Determining body composition
    • A61B5/4872—Body fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
FI20116008A 2011-10-12 2011-10-12 Viskeraalisen rasvan estäminen ja diagnostisointi FI20116008A0 (fi)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FI20116008A FI20116008A0 (fi) 2011-10-12 2011-10-12 Viskeraalisen rasvan estäminen ja diagnostisointi
PCT/FI2012/050979 WO2013054002A1 (en) 2011-10-12 2012-10-12 Prevention and diagnosis of visceral fat
EP12839611.6A EP2766026B1 (en) 2011-10-12 2012-10-12 Prevention and diagnosis of visceral fat
DK12839611.6T DK2766026T3 (en) 2011-10-12 2012-10-12 PREVENTION AND DIAGNOSIS OF VISCERAL FAT
ES12839611.6T ES2660396T3 (es) 2011-10-12 2012-10-12 Prevención y diagnosis de grasa visceral
US14/350,957 US10000818B2 (en) 2011-10-12 2012-10-12 Prevention and diagnosis of visceral fat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20116008A FI20116008A0 (fi) 2011-10-12 2011-10-12 Viskeraalisen rasvan estäminen ja diagnostisointi

Publications (1)

Publication Number Publication Date
FI20116008A0 true FI20116008A0 (fi) 2011-10-12

Family

ID=44883676

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20116008A FI20116008A0 (fi) 2011-10-12 2011-10-12 Viskeraalisen rasvan estäminen ja diagnostisointi

Country Status (6)

Country Link
US (1) US10000818B2 (fi)
EP (1) EP2766026B1 (fi)
DK (1) DK2766026T3 (fi)
ES (1) ES2660396T3 (fi)
FI (1) FI20116008A0 (fi)
WO (1) WO2013054002A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110201003A (zh) 2012-02-29 2019-09-06 伊西康内外科公司 微生物区系的组合物及与其相关的方法
US10633714B2 (en) 2013-07-21 2020-04-28 Pendulum Therapeutics, Inc. Methods and systems for microbiome characterization, monitoring and treatment
FI127483B (fi) * 2014-06-11 2018-07-13 Gut Guide Oy Mikrobiomarkkeri keliakialle ja siihen liittyvä tuote
SG10201903823QA (en) 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
EP3294308A4 (en) 2015-05-14 2019-03-06 University of Puerto Rico PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
CN105586293B (zh) * 2015-12-30 2018-09-25 四川剑南春（集团）有限责任公司 一种新的乳酸利用梭菌及其用途
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
EP4159224A1 (en) * 2017-06-30 2023-04-05 N.V. Nutricia Synbiotic composition for preventing chronic inflammation
EP3645024B1 (en) 2017-06-30 2022-09-14 N.V. Nutricia Synbiotic composition for preventing fatty liver disease
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
EP3705580A4 (en) * 2017-11-02 2021-01-13 Mitsubishi Chemical Corporation PROCEDURE FOR INTRAORAL INSPECTION USING INFORMATION FOR GROUPS OF BACTERIA ASSOCIATED WITH CLINICAL INDICES
CN113403375A (zh) * 2021-02-20 2021-09-17 北京金则医学检验实验室有限公司 一种用于预测儿童肥胖症的组合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI112504B (fi) 2002-08-07 2003-12-15 Cyflo Oy Menetelmä bakteerien tunnistamiseksi
EP2805625B2 (en) * 2005-02-28 2022-11-23 N.V. Nutricia Nutritional composition with prebiotics and probiotics
US20100172874A1 (en) * 2006-12-18 2010-07-08 The Washington University Gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
DE102006062250A1 (de) * 2006-12-22 2008-06-26 Roland Saur-Brosch Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
JPWO2008081834A1 (ja) * 2006-12-28 2010-04-30 江崎グリコ株式会社 グリコーゲンを含む食品とその用途
EP1974734A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
CA2707656C (en) * 2007-12-06 2018-05-22 Arla Foods Amba Probiotic bacteria and regulation of fat storage
WO2011005756A1 (en) * 2009-07-06 2011-01-13 Puretech Ventures, Llc Delivery of agents targeted to microbiota niches
DK2459203T3 (en) * 2009-07-30 2019-02-18 Dupont Nutrition Biosci Aps Lactic Acid Bacteria and Bifidobacteria for the Treatment of Endotoxemia
WO2011022660A1 (en) * 2009-08-21 2011-02-24 Puretech Ventures, Llc Methods of diagnosing and treating microbiome-associated disease using interaction network parameters
EP2308499A1 (en) * 2009-09-30 2011-04-13 Nestec S.A. Bifidobacterium longum ATCC BAA-999 (BL999) and weight control
US20160281142A1 (en) * 2015-03-25 2016-09-29 Nestec Sa Methods for predicting overweight risk for pets and adult percent body fat

Also Published As

Publication number Publication date
EP2766026B1 (en) 2017-11-29
EP2766026A4 (en) 2015-05-06
WO2013054002A1 (en) 2013-04-18
ES2660396T3 (es) 2018-03-22
US20140286920A1 (en) 2014-09-25
US10000818B2 (en) 2018-06-19
DK2766026T3 (en) 2018-03-05
EP2766026A1 (en) 2014-08-20

Similar Documents

Publication Publication Date Title
FI20116008A0 (fi) Viskeraalisen rasvan estäminen ja diagnostisointi
FI20116007A0 (fi) Serotoniinitason nostaminen ja diagnostisointi
MX2017014787A (es) Poblaciones bacterianas para promover la salud.
PH12015501291A1 (en) Functionalized exendin-4 derivatives
CA2941917C (en) Methods for the diagnosis and treatment of inflammatory bowel disease
WO2014169226A3 (en) Methods of diagnosing and treating chronic pain
PH12014502286A1 (en) Improving resistance to skeletal muscle fatigue
BR112013028709A2 (pt) cepas bacterianas capazes de metabolizar oxalatos
PH12016500475B1 (en) Food composition
BR112017025995A2 (pt) inibidor de igfbp3, composição farmacêutica para uso no tratamento e/ou prevenção de um distúrbio intestinal, método para o diagnóstico de um distúrbio intestinal em um indivíduo e kit para o diagnóstico de um distúrbio intestinal
CY1113661T1 (el) Προϊον τυριου εναλλακτικου τυπου και μεθοδος παραγωγης του ιδιου
IN2012DN06392A (fi)
MY174494A (en) Method for inhibiting pathogens using a nutritional composition
MX2015012205A (es) Productos de leche humana altos en grasa.
EP2538970A4 (en) TREATMENT OR PREVENTION OF INFECTION
EA201291440A1 (ru) Пробиотические штаммы для применения при повышении трансэпителиального сопротивления
PH12015500223B1 (en) Method for manufacturing low-protein rice and food using low-protein rice
WO2014026013A3 (en) Methods for maintaining or improving health, well-being and/or a physiological function in a subject
IN2012DN06393A (fi)
MX2018000189A (es) Metodo para el diagnostico de la enfermedad de farber.
MX2012003931A (es) Metodos para identificar animales con capacidad reducida para digerir lipidos y proteinas.
NZ762407A (en) Novel lactic acid bacteria and use thereof
UA105439U (uk) Спосіб діагностики дистрофічних змін в міокарді у робітників віброшумонебезпечних професій
NZ733721A (en) Methods for improving resistance to skeletal muscle fatigue
UA113144C2 (xx) Стійкі до фагів молочнокислі бактерії для текстурування харчових продуктів

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: GUT GUIDE OY

FD Application lapsed